Blog
EQS-News: EBA stress test proves Commerzbank’s high resilience
EQS-News: EBA stress test proves Commerzbank’s high resilience
ENOGIA: Resounding success of the capital increase with preferential subscription rights, in a total amount close to €4.6 million
ENOGIA: Resounding success of the capital increase with preferential subscription rights, in a total amount close to €4.6 million
Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)
Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)
EQS-Adhoc: Schweizer Electronic AG: High positive effects from deconsolidation and adjustment of the forecast for the 2023 financial year
EQS-Adhoc: Schweizer Electronic AG: High positive effects from deconsolidation and adjustment of the forecast for the 2023 financial year
Polymetal: Results of GM
Polymetal: Results of GM
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
EQS-Adhoc: PANTAFLIX AG intends capital increase in kind from authorized capital against contribution of a receivable in connection with the remuneration of a film production
EQS-Adhoc: PANTAFLIX AG intends capital increase in kind from authorized capital against contribution of a receivable in connection with the remuneration of a film production
EQS-News: Linde Publishes 2022 Sustainable Development Report
EQS-News: Linde Publishes 2022 Sustainable Development Report
Chelverton UK Dividend Trust plc: NAV-Net Asset Value(s)
Chelverton UK Dividend Trust plc: NAV-Net Asset Value(s)
RICHEMONT ACQUIRES A CONTROLLING STAKE IN GIANVITO ROSSI STARTING A PARTNERSHIP WITH ITS FOUNDER
RICHEMONT ACQUIRES A CONTROLLING STAKE IN GIANVITO
ROSSI STARTING A PARTNERSHIP WITH ITS FOUNDER
EQS-Adhoc: beaconsmind AG: beaconsmind AG aligns corporate structure around beaconsmind Group and accelerates growth
EQS-Adhoc: beaconsmind AG: beaconsmind AG aligns corporate structure around beaconsmind Group and accelerates growth
EQS-News: technotrans SE: Change in the Supervisory Board
EQS-News: technotrans SE: Change in the Supervisory Board
EQS-News: Muehlhan AG: Muehlhan AG publishes its results for the first half of 2023
EQS-News: Muehlhan AG: Muehlhan AG publishes its results for the first half of 2023
EQS-News: Deutsche Börse AG: PUBLICATION OF SUPPLEMENT NO. 2 TO EXTEND THE OFFER PERIOD OF THE VOLUNTARY RECOMMENDED PUBLIC TAKEOVER OFFER TO THE SHAREHOLDERS OF SIMCORP A/S UNTIL 19 SEPTEMBER 2023
EQS-News: Deutsche Börse AG: PUBLICATION OF SUPPLEMENT NO. 2 TO EXTEND THE OFFER PERIOD OF THE VOLUNTARY RECOMMENDED PUBLIC TAKEOVER OFFER TO THE SHAREHOLDERS OF SIMCORP A/S UNTIL 19 SEPTEMBER 2023
Nordea Bank Abp: Transaction in Own Shares
Nordea Bank Abp: Transaction in Own Shares
Metro Bank Holdings PLC: Capital Update
Metro Bank Holdings PLC: Capital Update
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
Launch of Irish Focused Fund
Launch of Irish Focused Fund
EQS-News: HENSOLDT increases order intake and profitability in the first half of 2023
EQS-News: HENSOLDT increases order intake and profitability in the first half of 2023
Evolva Holding SA: Evolva convenes extraordinary general meeting (EGM) for 24 August 2023 to secure financing until end of the year
Evolva Holding SA: Evolva convenes extraordinary general meeting (EGM) for 24 August 2023 to secure financing until end of the year
EQS-News: FUCHS successfully concludes first half-year
EQS-News: FUCHS successfully concludes first half-year
Solid sales and EBIT again in the first half of 2023 in a challenging environment
Solid sales and EBIT again in the first half of 2023 in a challenging environment
Comet slowed by semiconductor cycle; gradual recovery expected
Comet slowed by semiconductor cycle; gradual recovery expected
Solid result in difficult market environment
Solid result in difficult market environment
EQS-News: APONTIS PHARMA AG withdraws forecast for fiscal year 2023 and medium-term planning for 2026 – Preparation of program to increase operating performance and efficiency launched
EQS-News: APONTIS PHARMA AG withdraws forecast for fiscal year 2023 and medium-term planning for 2026 – Preparation of program to increase operating performance and efficiency launched


